TrueRelief Neuromodulation Device
Adjunctive treatment for post-surgical/post-traumatic acute pain; Relief of chronic intractable pain
ApprovedActive
Key Facts
Indication
Adjunctive treatment for post-surgical/post-traumatic acute pain; Relief of chronic intractable pain
Phase
Approved
Status
Active
Company
About TrueRelief
TrueRelief is a private medical device company commercializing a proprietary high-frequency electrical neuromodulation system for pain relief. Its core product is an FDA-cleared device that has demonstrated in a clinical trial a 47% reduction in opioid usage and improved pain scores in post-operative patients. The company targets the significant opioid crisis by offering a drug-free alternative for acute and chronic pain management through clinician-administered treatments. Its business model involves selling or leasing devices to healthcare providers and institutions.
View full company profile